Clinical characteristics, management and outcome of COVID-19-associated immune thrombocytopenia: a French multicentre series

Affiliations

• ¹ Department of Internal Medicine, National Referral Center for Adult's Immune Cytopenias Henri Mondor University Hospital, Assistance Publique Hôpitaux de Paris, Université Paris-Est Créteil, Créteil, France.
• ² Department of Internal Medicine, Toulouse University Hospital (CHU de Toulouse), Toulouse, France.
• ³ CIC 1436, Toulouse University Hospital (CHU de Toulouse), Toulouse, France.
• ⁴ UMR 1027 Inserm, University of Toulouse, Toulouse, France.
• ⁵ Department of Internal Medicine, University Hospital of Strasbourg, Research Team EA, 3072 "Mitochondrie, Stress oxydant et Protection musculaire", University of Strasbourg, Strasbourg, France.
• ⁶ Department of Internal Medicine, Bordeaux University Hospital (CHU de Bordeaux), Bordeaux, France.
• ⁷ Inserm U1034-University of Bordeaux, Bordeaux, France.
• ⁸ Department of Clinical Immunology, Saint Louis University Hospital, Assistance Publique Hôpitaux de Paris, Paris, France.
• ⁹ Department of internal medicine, Kremlin-Bicêtre, Assistance Publique Hôpitaux de Paris, Paris, France.
• ¹⁰ Inserm UMR-S 1140, Service d'Hématologie Biologique, Hôpital Européen Georges Pompidou, Assistance Publique Hôpitaux de Paris (AP-HP), Université de Paris, Paris, France.
• ¹¹ Department of Internal Medicine and Immunology, Claude-Huriez University Hospital, Université Lille Nord de France, Lille, France.
• ¹² Department of Internal Medicine, Albi Hospital, Albi, France.
• ¹³ Department of pneumology, Hôpital européen Georges Pompidou, Assistance Publique Hôpitaux de Paris, Paris, France.
• ¹⁴ Department of internal medicine, Nancy University Hospital (CHU de Nancy), University of Lorraine, Vandoeuvre-lès-Nancy, France.
• ¹⁵ Department of internal medicine, Hôpital la Timone, Assistance Publique Hôpitaux de Marseille, Aix Marseille Université, Marseille, France.